Particularly, together with T cells a VV encoding a secretory BiTA consisting of two scFvs specific for CD3 and EphA2 (EphA2-TEA-VV) had potent antitumor activity in comparison with control VVs plus T cells in a lung cancer xenograft model [47]. This evidence concerns the gene EPHA2 and lung carcinoma.